FILE:COV/COV-8K-20101112160502.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 
 
 
 
 
 
On November 11, 2010, Timothy R. Wright resigned from his position as Senior Vice President and President of our Pharmaceuticals segment, effective as of December 2, 2010. In addition to continuing in his position as the Chief Financial Officer of the Pharmaceuticals segment, Matthew Harbaugh will serve as interim President of the Pharmaceuticals segment until a successor to Mr. Wright is named.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: November 12, 2010


